The World Health Organization (WHO) has approved the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, a critical step in expanding global access to accurate and timely mpox testing. The Alinity m MPXV assay, produced by Abbott Molecular Inc., is a real-time PCR test that detects monkeypox virus DNA, aiding in the rapid confirmation of suspected cases. This move is particularly significant in countries experiencing mpox outbreaks, where quick and reliable testing is crucial for effective containment.